Mereu Liliana, Dalprà Francesca, Berlanda Valeria, Pertile Riccardo, Coser Daniela, Pecorino Basilio, D'Agate Maria Gabriella, Ciarleglio Francesco, Brolese Alberto, Tateo Saverio
Azienda Provinicale Servizi Sanitari, 38123 Trento, Italy.
Gynecologic and Obstetric Department, Ospedale Cannizzaro, Catania and Kore University, 94100 Enna, Italy.
Cancers (Basel). 2022 Dec 18;14(24):6243. doi: 10.3390/cancers14246243.
Objective: to evaluate the incidence of anastomotic leakage (AL), risk factors and utility of drainage and stoma in patients undergoing intestinal surgery for ovarian cancer in a single institution and in a review of the literature. Methods: retrospective study that includes consecutive patients undergoing debulking surgery with en bloc pelvic resection with rectosigmoid colectomy for ovarian cancer between 1 November 2011 and 31 December 2021. Data regarding patient and tumour characteristics, surgical procedure, hospitalisation, complications and follow-up were recorded and analysed. The PubMed database was explored for recent publications on this topic. Results: Seventy-five patients were enrolled in the study. All anastomoses were performed at a distance of >6 cm from the anal margin, with negative leak tests and tension-free anastomosis. Diverting stoma were performed in just three patients (4%). At least one perianastomotic pelvic drain was positioned in 71 patients (94.7%) and was removed on average on postoperative day 7. Four patients (5.3%) experienced AL. In all cases, the drain content was not the only sign of complication, as the clinical signs were also highly suggestive. Just one patient received conservative treatment. Average postoperative hospitalisation was 14.6 days (SD: ±9.7). There were no deaths at 30 and 60 days after surgery. Between the AL and non-AL groups, statistically significant differences were observed for age, Charlson Comorbidity Index, length of the intestinal resection and fitness for chemotherapy at 30 days. In ovarian cancer, rectosigmoid resection is a standardised procedure with comparable results for AL, and risk factors for AL are discretely homogeneous. What is neither homogeneous nor standardised according to the literature is the use of stomas and/or drains. Conclusion: use in the future of protective stoma and/or intra-abdominal drains is to be explored in selected and standardised situations to verify their preventive role.
在单一机构中评估卵巢癌肠道手术患者吻合口漏(AL)的发生率、危险因素以及引流和造口的作用,并进行文献综述。方法:回顾性研究,纳入2011年11月1日至2021年12月31日期间连续接受卵巢癌肿瘤细胞减灭术并整块盆腔切除及直肠乙状结肠切除术的患者。记录并分析有关患者和肿瘤特征、手术过程、住院情况、并发症及随访的数据。在PubMed数据库中检索关于该主题的近期出版物。结果:75例患者纳入研究。所有吻合口均在距肛缘>6 cm处进行,漏试验阴性且吻合无张力。仅3例患者(4%)行转流造口。71例患者(94.7%)至少放置了一根吻合口周围盆腔引流管,平均在术后第7天拔除。4例患者(5.3%)发生AL。在所有病例中,引流液并非并发症的唯一征象,临床体征也具有高度提示性。仅1例患者接受了保守治疗。术后平均住院时间为14.6天(标准差:±9.7)。术后30天和60天均无死亡病例。在AL组和非AL组之间,观察到年龄、Charlson合并症指数、肠道切除长度和术后30天化疗适应性存在统计学显著差异。在卵巢癌中,直肠乙状结肠切除术是一种标准化手术,AL发生率结果相当,且AL的危险因素离散度均匀。根据文献,造口和/或引流的使用既不均匀也不标准化。结论:未来应在选定的标准化情况下探索使用保护性造口和/或腹腔内引流,以验证其预防作用。